Navigation Links
Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
Date:8/27/2007

Princeton, N.J., Aug. 27 /PRNewswire-FirstCall/ -- Pharmacopeia (Nasdaq: PCOP), an innovator in the discovery and development of novel small molecule therapeutics, announced today that the company will assist the World Health Organization's Special Program for Research and Training in Tropical Diseases (WHO/TDR) in its efforts to develop novel antimalarial agents. Pharmacopeia will receive funding to conduct medicinal chemistry research on compounds identified through WHO/TDR's drug screening program involving a network of centers in developed and developing countries. The goal of this project is to identify new lead series with the potential to become novel malaria drug candidates. Malaria kills more than one million people a year, with most of those being children in the developing world.

For more information about Pharmacopeia, please visit http://www.pharmacopeia.com.

Contact:

Amy Sharpless

609-452-3643

ir_pr@pcop.com


'/>"/>
SOURCE Pharmacopeia
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Pharmacopeia Announces Positive Results from Initial DARA Clinical Trial
2. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
3. MAP Pharmaceuticals to Present Unit Dose Budesonide Phase 2 Clinical Data at the World Asthma Meeting
4. Active Biotech presents new pre-clinical data for the 57-57 project at the 8th World Congress on Inflammation
5. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
6. World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester
7. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
8. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
9. Gentiums Defibrotide Highlighted in Poster Presentation at World Congress of Nephrology
10. Onconase has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
11. Ace Biosciences, Ace393, the Worlds First Commercial Vaccine for Travellers Diarrhoea Caused by Campylobacter Successfully Completes Phase I Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2018)... , ... August 07, 2018 , ... Braun Ambulances is ... 8th-10th at Kay Bailey Hutchison Convention Center in Dallas, Texas. Braun Ambulances will have ... and one Liberty model. , Fire Rescue International (FRI) is the International Association ...
(Date:8/3/2018)... ... August 03, 2018 , ... LifeWIRE’s innovative patents in ... of the 5,000-strong association of app companies and information technology firms across the ... Notification Method System and Computer Program Product” and subsequent patents are among those ...
(Date:8/2/2018)... Md. (PRWEB) , ... August 02, 2018 , ... UMD ... up to $7.7 million over 5 years from the National Institute of Allergy and ... tick research program to understand the immune responses of ticks that contribute to the ...
Breaking Medicine Technology:
(Date:8/15/2018)... ... , ... Today David Hyde Apparel debuts the first, fully effective sweat-proof and ... desire for confidence and comfort year-round, the new shirt leverages a patent-pending, double-sided fabric ... most humid of climates. , The brainchild of two recent University of Central Florida ...
(Date:8/14/2018)... ... August 14, 2018 , ... Gastro ... new leadership roles for healthcare executives Simon Frisch and Chris Weinstein, who have ... They assume their roles at a time of tremendous growth for the group, ...
(Date:8/11/2018)... , ... August 10, 2018 , ... Dr. Siavash Eftekhari, ... to Asunción, Paraguay for a week-long international outpost trip to deliver dental care in ... colleagues and support staff, Dr. Eftekhari volunteered his time to help deliver care to ...
(Date:8/9/2018)... , ... August 09, 2018 , ... ... realize their implants have ruptured, according to cross-referenced data from The American Society ... silicone gel implant rupture rates monitored by the FDA. As an MRI is ...
(Date:8/9/2018)... (PRWEB) , ... August 09, 2018 , ... ... Jim and Kathy Coover and the company’s independent distributors, customers, and employees, the ... 24 hours of fundraising, exceeding the $2 million goal. 100 percent of the ...
Breaking Medicine News(10 mins):